GLP-2 TZ 10MG : DUAL ACTION WEIGHT LOSS RESEARCH PEPTIDE

Sale!

48 in stock

Original price was: $115.00.Current price is: $95.00.

SKU WR4 Categories ,

Description

Legal Disclaimer

This information has not been reviewed or endorsed by the US FDA. It is provided solely for educational and research purposes. TZ 2 is not approved for medical use, human consumption, or as a therapeutic treatment.


Product Details

  • Quantity: 10mg per vial
  • Purity: ≥99%, Rigorous third-party testing
  • Packaging: Secure, sealed, and tamper-proof vials
  • Source: Synthesized using advanced peptide synthesis techniques
  • Note: This product is sold in lyophilized powder form and must be reconstituted before use.

Overview

A revolutionary tool in metabolic and obesity research, TZ 2 is a dual-receptor agonist that targets both GLP-1 and GIP receptors. This combination enhances the peptide’s effectiveness in regulating appetite, managing blood glucose levels, and improving insulin sensitivity. With its unique dual mechanism of action, TZ 2 provides a more advanced model for researchers investigating weight loss, hormonal balance, and type 2 diabetes.


Research Specifics

  • Metabolic Research: Studied for its ability to enhance insulin sensitivity and promote energy efficiency.
  • Obesity Studies: Shown to support significant bodyweight reduction and improved fat-to-lean mass ratio.
  • Diabetes Research: Actively explored for its glucose-lowering effects and support in managing insulin resistance.
  • Hormonal Regulation: Offers insight into the interaction of incretin pathways and their role in appetite and metabolic health.

Technical Specifications

  • Molecular Formula: C225H348N48O68
  • Purity: ≥99% (HPLC-verified)
  • Form: Lyophilized powder
  • Storage: Store at -20°C for long-term stability
  • Solubility: Requires reconstitution with sterile bacteriostatic water or a suitable solvent before use

 

Reviews

There are no reviews yet.

Be the first to review “GLP-2 TZ 10MG : DUAL ACTION WEIGHT LOSS RESEARCH PEPTIDE”

Your email address will not be published. Required fields are marked *

Please Choose Your Country